Get started
ASTELLAS PHARMA INCASTELLAS PHARMA INCASTELLAS PHARMA INC

ASTELLAS PHARMA INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast

4503/N chart


Full chart

4503/N upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪385.28 B‬ MXN
Dividend yield (indicated)
4.61%
Price to earnings Ratio (TTM)
35.80
Basic EPS (TTM)
5.93 MXN
Net income (FY)
‪6.93 B‬ MXN
Revenue (FY)
‪261.16 B‬ MXN
Shares float
‪1.71 B‬
Beta (1Y)
0.61

Employees


Employees (FY)
‪13.64 K‬
Change (1Y)
‪−1.11 K‬ −7.53%
Revenue / Employee (1Y)
‪19.14 M‬ MXN
Net income / Employee (1Y)
‪507.98 K‬ MXN

About ASTELLAS PHARMA


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Naoki Okamura
Website
astellas.com
Headquarters
Tokyo
Founded
1923
ISIN
JP3942400007
FIGI
BBG01255KWN9
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Check out other big names from the same industry as 4503/N.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4503/N news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of 4503/N is 215.42 MXN — it has increased by 4.24% in the past 24 hours. Watch ASTELLAS PHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange ASTELLAS PHARMA INC stocks are traded under the ticker 4503/N.
4503/N stock has risen by 6.05% compared to the previous week, the month change is a 6.05% rise, over the last year ASTELLAS PHARMA INC has showed a 6.05% increase.
We've gathered analysts' opinions on ASTELLAS PHARMA INC future price: according to them, 4503/N price has a max estimate of 280.62 MXN and a min estimate of 165.82 MXN. Watch 4503/N chart and read a more detailed ASTELLAS PHARMA INC stock forecast: see what analysts think of ASTELLAS PHARMA INC and suggest that you do with its stocks.
4503/N stock is 4.09% volatile and has beta coefficient of 0.61. Track ASTELLAS PHARMA INC stock price on the chart and check out the list of the most volatile stocks — is ASTELLAS PHARMA INC there?
Today ASTELLAS PHARMA INC has the market capitalization of ‪383.21 B‬, it has increased by 3.06% over the last week.
Yes, you can track ASTELLAS PHARMA INC financials in yearly and quarterly reports right on TradingView.
ASTELLAS PHARMA INC is going to release the next earnings report on Oct 29, 2025. Keep track of upcoming events with our Earnings Calendar.
4503/N earnings for the last quarter are 4.97 MXN per share, whereas the estimation was 2.59 MXN resulting in a 92.33% surprise. The estimated earnings for the next quarter are 3.21 MXN per share. See more details about ASTELLAS PHARMA INC earnings.
ASTELLAS PHARMA INC revenue for the last quarter amounts to ‪65.84 B‬ MXN, despite the estimated figure of ‪59.16 B‬ MXN. In the next quarter, revenue is expected to reach ‪61.09 B‬ MXN.
4503/N net income for the last quarter is ‪8.91 B‬ MXN, while the quarter before that showed ‪10.23 B‬ MXN of net income which accounts for −12.93% change. Track more ASTELLAS PHARMA INC financial stats to get the full picture.
ASTELLAS PHARMA INC dividend yield was 5.12% in 2024, and payout ratio reached 261.05%. The year before the numbers were 4.26% and 736.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 24, 2025, the company has ‪13.64 K‬ employees. See our rating of the largest employees — is ASTELLAS PHARMA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTELLAS PHARMA INC EBITDA is ‪66.19 B‬ MXN, and current EBITDA margin is 23.78%. See more stats in ASTELLAS PHARMA INC financial statements.
Like other stocks, 4503/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTELLAS PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.